The emerging approach of this peptide represents a major development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide886982.bligblogging.com/42806119/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment